share_log

HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Lowers Price Target to $11

Benzinga ·  Aug 10 04:53  · Ratings

HC Wainwright & Co. analyst Emily Bodnar maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price target from $12 to $11.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment